Guardian Pharmacy Q4 revenue $397.6M (+17% YoY), net income $21.3M (+81%); raises 2026 EBITDA guidance

Guardian Pharmacy Services, Inc.

Q4 diluted EPS $0.33, adjusted EPS $0.37; full-year diluted EPS $0.78, adjusted EPS $1.07.
Full-year revenue $1.45B (+18% YoY); net income $49.0M vs $71.0M loss in 2024.
2026 Adjusted EBITDA guidance raised to $120M–$124M (from $115M–$118M); revenue guidance unchanged $1.40B–$1.42B.
Cash $65.6M at year-end, no long-term debt outstanding under $75M credit facility.
Annualized return on equity approximately 27% in 2025; 54 full-service pharmacies after North Ridge acquisition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.